Naurex's Acquisition

Naurex was acquired by Allergan on July 27, 2015.

Naurex is a biopharmaceutical company developing novel modulators of the NMDA receptor to treat challenging diseases of the central nervous system (CNS). The company's first-generation compound, GLYX-…

Articles about Naurex's Acquisition: